Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus

Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

6,424 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus trial results

Completed

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

NCT02128932

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Ozark, Alabama, United States
  • Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
  • Novo Nordisk Investigational Site Gilbert, Arizona, United States
View all 231 locations
View Trial Details
Completed

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

NCT01831765

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Mobile, Alabama, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
View all 191 locations
View Trial Details
Completed

Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

NCT01850615

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
View all 58 locations
View Trial Details
Completed

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes

NCT02500706

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Encino, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 152 locations
View Trial Details
Completed

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes

NCT02054897

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Anniston, Alabama, United States
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Pell City, Alabama, United States
  • Novo Nordisk Investigational Site Hawaiian Gardens, California, United States
View all 86 locations
View Trial Details
Completed

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

NCT02305381

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Lomita, California, United States
View all 99 locations
View Trial Details
Completed

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

NCT02582242

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
Locations
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Oran, Algeria
  • Novo Nordisk Investigational Site Hefei, Anhui, China
View all 50 locations
View Trial Details
Completed

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

NCT01835431

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 73 locations
View Trial Details

Related conditions